메뉴 건너뛰기




Volumn 36, Issue 4, 2009, Pages 447-454

Preliminary in vivo and ex vivo evaluation of the 5-HT2A imaging probe [18F]MH.MZ

Author keywords

5 HT2A receptor; Altanserin; Fluorine 18; MDL 100907; MH.MZ; PET

Indexed keywords

2 FLUOROETHYLTOSYLATE F 18; FLUORINE 18; MH MZ F 18; SEROTONIN 2A RECEPTOR; TRACER; UNCLASSIFIED DRUG;

EID: 67349246459     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2009.01.012     Document Type: Article
Times cited : (23)

References (25)
  • 2
    • 0001273241 scopus 로고    scopus 로고
    • Jones B.E., Kryger M.H., Roth T., and Dement W.C. (Eds), W.B. Saunders Company, Philadelphia
    • In: Jones B.E., Kryger M.H., Roth T., and Dement W.C. (Eds). Principles and practice of sleep medicine (2000), W.B. Saunders Company, Philadelphia 134-154
    • (2000) Principles and practice of sleep medicine , pp. 134-154
  • 3
    • 0024466603 scopus 로고
    • Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values
    • Meltzer H.Y., Matsubara S., and Lee J.C. Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values. J Pharmacol Exp Ther 251 (1989) 238-246
    • (1989) J Pharmacol Exp Ther , vol.251 , pp. 238-246
    • Meltzer, H.Y.1    Matsubara, S.2    Lee, J.C.3
  • 10
    • 0031944188 scopus 로고    scopus 로고
    • Serotonin in aging, late-life depression, and Alzheimer's disease: the emerging role of functional imaging
    • Meltzer C.C., Smith G., DeKosky S.T., Pollock B.G., Mathis C.A., Moore R.Y., et al. Serotonin in aging, late-life depression, and Alzheimer's disease: the emerging role of functional imaging. Neuropsychopharmacology 18 (1998) 407-430
    • (1998) Neuropsychopharmacology , vol.18 , pp. 407-430
    • Meltzer, C.C.1    Smith, G.2    DeKosky, S.T.3    Pollock, B.G.4    Mathis, C.A.5    Moore, R.Y.6
  • 13
    • 0024408834 scopus 로고
    • Circumscribed changes of the cerebral cortex in neuropsychiatric disorders of later life
    • Bowen D.M., Najlerahim A., Procter A.W., Francis P.T., and Murphy E. Circumscribed changes of the cerebral cortex in neuropsychiatric disorders of later life. Proc Natl Acad Sci 86 (1989) 9504-9508
    • (1989) Proc Natl Acad Sci , vol.86 , pp. 9504-9508
    • Bowen, D.M.1    Najlerahim, A.2    Procter, A.W.3    Francis, P.T.4    Murphy, E.5
  • 14
    • 0025917989 scopus 로고
    • Cortical serotonin-S2 receptor binding in Lewy body dementia. Alzheimer's and Parkinson's diseases
    • Cheng A.V., Ferrier I.N., Morris C.M., Jabeen S., Sahgal A., McKeith I.G., et al. Cortical serotonin-S2 receptor binding in Lewy body dementia. Alzheimer's and Parkinson's diseases. J Neurol Sci 106 (1991) 50-55
    • (1991) J Neurol Sci , vol.106 , pp. 50-55
    • Cheng, A.V.1    Ferrier, I.N.2    Morris, C.M.3    Jabeen, S.4    Sahgal, A.5    McKeith, I.G.6
  • 15
    • 18744402189 scopus 로고    scopus 로고
    • 2A receptors in the postmortem temporal cortex correlates with rate of cognitive decline in Alzheimer's disease
    • 2A receptors in the postmortem temporal cortex correlates with rate of cognitive decline in Alzheimer's disease. Psychopharmacology 179 (2005) 673-677
    • (2005) Psychopharmacology , vol.179 , pp. 673-677
    • Lai, M.K.1    Tsang, S.W.2    Alder, J.T.3    Keene, J.4    Hope, T.5    Esiri, M.M.6
  • 24
    • 0032080844 scopus 로고    scopus 로고
    • 2A receptor antagonist (MDL 100,907) and an active metabolite (MDL 105,725) using in vivo microdialysis sampling in the rat
    • 2A receptor antagonist (MDL 100,907) and an active metabolite (MDL 105,725) using in vivo microdialysis sampling in the rat. J Pharm Biomed Anal 17 (1998) 17-25
    • (1998) J Pharm Biomed Anal , vol.17 , pp. 17-25
    • Scott, D.O.1    Heath, T.G.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.